NCT01127243

Brief Summary

The purpose of this study is to determine if women subjected to laparoscopic supracervical hysterectomy in a day-case setting would be less satisfied with the length of hospital stay when compared with women who had an overnight stay following their surgical procedure. The null hypothesis was that there was no difference in satisfaction with length of hospital stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 20, 2010

Completed
Last Updated

May 20, 2010

Status Verified

June 1, 2009

Enrollment Period

1 year

First QC Date

May 19, 2010

Last Update Submit

May 19, 2010

Conditions

Keywords

Hysterectomylaparoscopyday-case surgeryquality of lifeAmbulatory Surgical Procedures

Outcome Measures

Primary Outcomes (1)

  • satisfaction with the length of stay in the hospital

    satisfaction was measured on a 10-point visual analogue scale

    on the 7th postoperative day

Secondary Outcomes (1)

  • health-related quality of life

    measured on days 1, 2, 4 and 7 following surgery

Study Arms (2)

inpatient LSH

ACTIVE COMPARATOR

LSH means laparoscopic supracervical hysterectomy

Procedure: inpatient LSH

Day-case LSH

EXPERIMENTAL

LSH means laparoscopic supracervical hysterectomy

Procedure: day-case laparoscopic supracervical hysterectomy

Interventions

patients discharged home the same day of the operation

Also known as: day surgery, day-case, outpatient surgery
Day-case LSH
inpatient LSHPROCEDURE

patients discharged home the day after the operation

Also known as: inpatient, overnight stay
inpatient LSH

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • women requiring a hysterectomy for benign conditions

You may not qualify if:

  • previous history of cervical dysplasia, an abnormal smear test within the last two to three years,
  • abnormal histology or cytology at endometrial sampling,
  • a history of endometriosis,
  • advanced endometriosis diagnosed intra-operatively,
  • previous major abdominal or pelvic surgery (patients with previous caesarean section were considered as eligible),
  • a mental disorder or somatic disease that would interfere with a normal recovery pattern such as substance dependence disorder,
  • psychosis, or American Society of Anaesthesiologists (ASA) rating 3 and 4 patients, and
  • inability to understand and execute oral and written Norwegian language.
  • women were also excluded from the study if they did not have an adult carer (a relative or a friend) staying with them during the first night after discharge; or they were living or staying at a hotel more than an hour's drive from the hospital; and if they did not have access to a telephone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital, Ullevål

Oslo, Oslo County, 0407, Norway

Location

MeSH Terms

Interventions

Ambulatory Surgical ProceduresInosine Monophosphate

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeInosine NucleotidesPurine NucleotidesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsNucleotidesNucleic Acids, Nucleotides, and NucleosidesRibonucleotides

Study Officials

  • Jelena Kisic-Trope, MD, Msc

    Oslo University Hospital, Ullevål

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 19, 2010

First Posted

May 20, 2010

Study Start

June 1, 2008

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

May 20, 2010

Record last verified: 2009-06

Locations